Brazilian Journal of Anesthesiology
https://app.periodikos.com.br/journal/rba/article/doi/10.1590/S0034-70942005000600005
Brazilian Journal of Anesthesiology
Scientific Article

Bloqueio neuromuscular residual após o uso de rocurônio ou cisatracúrio

Residual neuromuscular block after rocuronium or cisatracurium

Bruno Salomé de Morais; Carlos Henrique Viana de Castro; Vera Coelho Teixeira; Alexandre Silva Pinto

http://dx.doi.org/10.1590/S0034-70942005000600005 Braz J Anesthesiol, vol.55, n6, p.622-630, 2005
PDF Português
PDF English
Downloads: 9
Views: 1888

Resumo

JUSTIFICATIVA E OBJETIVOS: O bloqueio neuromuscular residual na sala de recuperação pós-anestésica (SRPA) é um fenômeno que pode aumentar a morbidade pós-operatória, com incidência variando entre 0% e 93%. O objetivo deste estudo foi avaliar a incidência do bloqueio neuromuscular residual na SRPA. MÉTODO: Foram estudados 93 pacientes submetidos à cirurgia geral com o uso de cisatracúrio ou rocurônio. Após a admissão na SRPA foi realizada a monitorização objetiva da função neuromuscular (aceleromiografia - TOF GUARD). O bloqueio neuromuscular residual foi definido como SQE < 0,9. RESULTADOS: Do total de 93 pacientes, 53 receberam cisatracúrio e 40 rocurônio. As características demográficas, duração do procedimento e o uso de antagonista foram comparáveis em ambos os grupos. O bloqueio neuromuscular residual foi de 32% no subgrupo C (cisatracúrio) e 30% no subgrupo R (rocurônio). O bloqueio neuromuscular residual não foi associado à dose, idade, ou uso de antagonista, porém apresentou relação com a duração do procedimento cirúrgico. No subgrupo C o tempo médio de cirurgia foi 135 minutos nos pacientes com bloqueio neuromuscular e 161 minutos nos pacientes sem bloqueio, p < 0,029. No subgrupo R o tempo médio de cirurgia foi 122 e 150 minutos, respectivamente, p < 0,039. CONCLUSÕES: Os pacientes de ambos os grupos apresentaram incidência elevada de bloqueio neuromuscular residual na SRPA. A curarização residual pós-operatória continua um problema mesmo com os novos bloqueadores neuromusculares de ação intermediária. É de suma importância a monitorização objetiva de todos os pacientes submetidos à anestesia geral com uso de bloqueador neuromuscular.

Palavras-chave

BLOQUEADORES NEUROMUSCULARES, BLOQUEADORES NEUROMUSCULARES, MONITORIZAÇÃO, MONITORIZAÇÃO, RECUPERAÇÃO PÓS- ANESTÉSICA

Abstract

BACKGROUND AND OBJECTIVES: Residual neuromuscular block in the post-anesthetic recovery unit (PACU) may increase postoperative morbidity from 0% to 93%. This study aimed at evaluating the incidence of residual neuromuscular block in the PACU. METHODS: Participated in this study 93 patients submitted to general anesthesia with cisatracurium or rocuronium. After PACU admission, neuromuscular function was objectively monitored (acceleromyography - TOF GUARD). Residual neuromuscular block was defined as TOF < 0.9. RESULTS: From 93 patients, 53 received cisatracurium and 40 rocuronium. Demographics, procedure length and the use of antagonists were comparable between groups. Residual neuromuscular block was 32% in subgroup C (cisatracurium) and 30% in subgroup R (rocuronium). Residual neuromuscular block was unrelated to dose, age and use of antagonists, but was related to procedure length. In subgroup C, mean procedure length was 135 minutes for patients with neuromuscular block and 161 minutes for patients without (p < 0.029). In subgroup R, mean surgery length was 122 and 150 minutes, respectively (p < 0.039). CONCLUSIONS: Both groups had high incidence of residual neuromuscular block in the PACU. Residual postoperative curarization is still a problem even with new intermediary action neuromuscular blockers. It is highly important to objectively monitor all patients submitted to general anesthesia with neuromuscular blockers.

Keywords

MONITORING, MONITORING, NEUROMUSCULAR BLOCKERS, NEUROMUSCULAR BLOCKERS, POST-ANESTHETIC RECOVERY

References

Baillard C, Gehan G, Reboul-Marty J. Residual curarization in the recovery room after vecuronium. Br J Anesth. 2000;84:394-395.

Berg H, Roed J, Viby-Mogensen J. Residual neuromuscular block is a risk factor for postoperative pulmonary complications: A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41:1095-1103.

Oliveira AS, Bastos CO, Serafim MM. Avaliação do bloqueio neuromuscular residual na sala de recuperação pós-anestésica. Rev Bras Anestesiol. 1997;47:502-511.

McCaul C, Tobin E, Boylan JF. Atracurium is associated with postoperative residual curarization. Br J Anaesth. 2002;89:766-769.

Kim KS, Lew SH, Cho HY. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesth Analg. 2002;95:1656-1660.

Cammu G, Baerdemaeker L, den Blauwen N. Postoperative residual curarization with cisatracurium and rocuronium infusions. Eur J Anaesthesiol. 2002;19:129-134.

Tiret L, esmonts JM, Hatton F. Complications associated with anesthesia - a prospective survey in France. Can Anaesth Soc J. 1986;33:336-344.

Griffth HR, Johnson GE. The use of curare in general anesthesia. Anesthesiology. 1942;3:418.

Eriksson LI. The effects of residual neuromuscular blockade and volatile anesthetics on the control of ventilation. Anesth Analg. 1999;89:243-251.

Gill S, Donati F, Bevan DR. Clinical evaluation of double burst stimulation: Its relatioship to train of four stimulation. Anesthesia. 1989;45:543.

Drenck NE, Ueda N, Olsen NV. Manual evaluation of residual curarization using double burst stimulation: a comparison with train of four. Anesthesiology. 1989;70:578-581.

Tardelli MA. Monitorização do Bloqueio Neuromuscular. Curso de Educação à Distância em Anestesiologia. 2002:177-190.

Eriksson LI, Sundman E, Olsson R. Funcional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology. 1997;87:1035-1043.

Bevan DR, Kahwaji R, Ansermino JM. Residual block after mivacurium with or without edrophonium reversal in adults and children. Anesthesiology. 1996;84:362-367.

Lepage JY, Malinovsky JM, Malinge M. Pharmacodinamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2 - opioid anesthesia. Anesth Analg. 1996;83:823-829.

Kopman AF, Zank LM, Neuman GG. Antagonism of cisatracurium and rocuronium block at a tactile Train-of-Four count of 2: should quantitative assessment of neuromuscular function be mandatory. Anesth Analg. 2004;98:102-106.

5dd6ce6c0e88250d6013f286 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections